Sep 19, 2026
Humanized Antibody QX007N Shows Promise for Treating IL-33-Driven Airway Inflammation
A research team led by Prof. FENG Wei from the Institute of Biophysics of the Chinese Academy of Sciences, in collaboration with QX Biopharmaceuticals, has identified the molecular mechanism by which the humanized monoclonal antibody QX007N neutralizes interleukin-33 (IL-33). IL-33 is a key regulator of immune responses that is implicated in inflammatory and allergic diseases, such as asthma and chronic obstructive pulmonary disease (COPD).
Health;Bioengineering